samedan logo
home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market 

For further information please contact:

Simon Caplan

Will Brown

We're also on Twitter! Follow us @PMPSmag  



Click here to view the digital version of PMPS



Click here to view the digital version of the Parenteral Technology Supplement


Featured in this issue
Parenteral Technology Supplement
Choosing the Right Packaging

Cecilia Bassi at Bormioli Pharma

Packaging is a critical factor of success for parenteral medicine. In fact, packaging and drug formulation actually must go along in terms of development, and choosing the right container for a drug is all but an easy task. This is true in the pharmaceutical industry in general and, above all, when it comes to parenteral drugs.

Parenteral dosage forms differ from all other drugs because they are injected directly into the tissue through the primary protective systems of the human body, such as skin and mucous membranes.
Packaging Potent Products
Achieving Zero Defects in a Pandemic

Massimo Mainetti at Datwyler

As the COVID-19 pandemic continues to unfold, the industry is working tirelessly to identify an effective treatment and vaccine. Amid the pressure to produce a vaccine in such a short time frame, there is also the pressure to ensure no valuable time and resources are wasted. Naturally, treatments that are being considered are large molecule drugs, which require manufacturers to address challenges with achieving zero defects and silicone contamination stemming from packaging and delivery.
  Collaboration in Pharma
From Manufacturing to Supply

Randy Peoples at DHL and Ira Smith at Peli BioThermal

The rise of industry concern about green initiatives has been growing for decades. This has had an impact on how individual citizens view their own decisions regarding their actions, the policies of their governments, and the actions of companies they patronise.


Published quarterly in
February, May,
August, and November


News and Press Releases

Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2- neutralizing antibody for the therapy of COVID-19

Vilnius, Lithuania, and Schlieren, Switzerland August 11, 2020 Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to manufacture MTxs therapeutic COVID-19 antibody candidate in a 4-month fast-track process approved by regulatory authorities.
More info >>

White Papers

Environmental Factors in Data Centres


In addition to temperature and humidity, there are many more constraints in the environment that increase failure rates, explains Emilio Sapia of Secure Techincal Rooms.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement